Extendicare (TSE:EXE – Free Report) had its price target boosted by BMO Capital Markets from C$15.00 to C$21.00 in a report published on Monday,BayStreet.CA reports.
A number of other research analysts have also recently issued reports on EXE. CIBC lifted their price target on shares of Extendicare from C$18.00 to C$22.00 in a research report on Thursday, November 13th. National Bankshares raised their target price on shares of Extendicare from C$16.10 to C$17.50 and gave the company an “outperform” rating in a research note on Wednesday, October 8th. Cibc World Mkts upgraded shares of Extendicare to a “strong-buy” rating in a report on Monday, September 22nd. Finally, TD Securities upped their price target on Extendicare from C$15.00 to C$19.00 in a research note on Thursday, November 13th. Two research analysts have rated the stock with a Strong Buy rating, two have given a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of C$18.10.
Extendicare Price Performance
Extendicare Announces Dividend
The firm also recently disclosed a monthly dividend, which was paid on Monday, November 17th. Investors of record on Monday, November 17th were given a $0.042 dividend. The ex-dividend date of this dividend was Friday, October 31st. This represents a c) annualized dividend and a yield of 2.5%. Extendicare’s dividend payout ratio is 46.60%.
Extendicare Company Profile
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.
Read More
- Five stocks we like better than Extendicare
- How to Most Effectively Use the MarketBeat Earnings Screener
- onsemi Places a $6 Billion Bet on Its Own Stock
- Comparing and Trading High PE Ratio Stocks
- HIMS Has Been a Roller Coaster Ride. Should Investors Hop On?
- The Role Economic Reports Play in a Successful Investment Strategy
- End the Year Strong With These 3 Comeback Champions
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.
